Protego

Series-B+
protegobio.com Biotech & Healthcare
Total Funding $2M
Latest Round Undisclosed Series-B+
Last Announced Dec 1, 2025
Investors Undisclosed
Decision Makers 6 Verified

About Protego

Protego Bio is a clinical-stage biotech developing first-in-class small molecule pharmacological chaperones for AL amyloidosis and other protein misfolding diseases.

Sectors & Market Categories

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-B+
Global Headquarters Undisclosed
Tracked Since Oct 1, 2026

Web & Domain Identity

Official Website protegobio.com
Domain Registered Date May 14, 2024

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Not linked

Company Milestones & Timeline

3 Events
  1. Capital Raise

    Series-B+ announced

    fundraisingfox.com

  2. Milestone

    Website domain registered

    protegobio.com

  3. Capital Raise

    Raised $2,000,000 · Seed

    startupintros.com

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for Protego.

Funding History

2 Rounds
Series-B+ · Dec 1, 2025
Seed · May 9, 2018

Founders & Leadership

2

Pablo Rojas

Co-founder, CEO

Work email & phone locked Unlock →

Rafael Casabianca

Co-Founder & CTO (YC S21)

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts